New epilepsy drug shows promise for long-term seizure control
NCT ID NCT07563634
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at the long-term safety of brivaracetam, a drug added to existing epilepsy treatments for people with uncontrolled focal seizures. 141 Chinese adults who completed a prior trial took brivaracetam for up to a year or more. Researchers tracked side effects and seizure frequency to see if the drug remains safe and effective over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- brivaracetam
- What this could lead to
- If successful, this could confirm brivaracetam as a safe and effective long-term add-on treatment for people with focal epilepsy that isn't controlled by other medications.
- What could go wrong
- This is an open-label study with no placebo group, so results may be less reliable. Side effects like dizziness or drowsiness are possible, and not everyone may benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY, FOCAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Huashan Hospital, Fudan University
Shanghai, Shanghai Municipality, 200040, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.